Prospective study of cenobamate on cognition, affectivity and quality of life in focal epilepsy.
Judit Catalán-AguilarKevin G HampelIrene Cano-LópezMercedes GarcésAlejandro Lozano-GarcíaPaula Tormos-PonsEsperanza González-BonoVicente VillanuevaPublished in: Epilepsia open (2023)
These results suggest that cenobamate is a safe antiseizure medication in terms of cognition, negative affectivity, or quality of life since no adverse events have been found after three and six months of treatment.